Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 13, 2024

Omission of Axillary Dissection After Nodal Downstaging With Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

JAMA Oncology


Additional Info

JAMA Oncology
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
JAMA Oncol 2024 Apr 25;[EPub Ahead of Print], G Montagna, MM Mrdutt, SX Sun, C Hlavin, EJ Diego, SM Wong, AV Barrio, AB van den Bruele, N Cabioglu, V Sevilimedu, LH Rosenberger, ES Hwang, A Ingham, B Papassotiropoulos, BD Nguyen-Sträuli, C Kurzeder, DD Aybar, D Vorburger, DM Matlac, E Ostapenko, F Riedel, F Fitzal, F Meani, F Fick, J Sagasser, J Heil, H Karanlik, KJ Dedes, L Romics, M Banys-Paluchowski, M Muslumanoglu, MDRC Perez, MC Díaz, M Heidinger, MK Fehr, M Reinisch, M Tukenmez, N Maggi, N Rocco, N Ditsch, OD Gentilini, RR Paulinelli, SS Zarhi, S Kuemmel, S Bruzas, S di Lascio, TK Parissenti, TL Hoskin, U Güth, V Ovalle, C Tausch, HM Kuerer, AS Caudle, JF Boileau, JC Boughey, T Kühn, M Morrow, WP Weber

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading